Press releases
September 30, 2025
Inflammatix Announces Three Landmark Publications in Nature Medicine that Redefine Acute Infection and Sepsis Diagnosis and Treatment
September 4, 2025
Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of TriVerity™ Test System
June 10, 2025
Inflammatix Names Martín Vazquez as Chief Operating Officer to Drive National Scale-Up of TriVerity™ Test System
March 25, 2025
Inflammatix Ships TriVerity™ Test Cartridges and Myrna™ Instruments to the U.S. Military
January 21, 2025
Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test
November 11, 2024
Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial
October 10, 2024
Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team
October 1, 2024
Inflammatix Presents Data at ACEP24 Showing High Diagnostic and Prognostic Accuracy of its TriVerity™ Test Regardless of Patient Immune Status
